I'm talking about Histogen and Replicel in particular.
We know why/how they could help native follicles to replenish their storage of stem cells and recover from the damages of DHT.
But what about transplanted follicles?
Some of them lose caliber with time; among those, few do so due to DHT (i.e. they were DHT sensitive in the donor area), but most do so because stem cell exhaustion (due to the original damage during extraction, handling and insertion... a sort of premature aging).
My question is: are these new therapies going to bring some benefit to those follicles, as well?
From what I understand from the theory behind, the answer could be 'yes', but I'm not an expert at all, so I'd like to hear from you.
We know why/how they could help native follicles to replenish their storage of stem cells and recover from the damages of DHT.
But what about transplanted follicles?
Some of them lose caliber with time; among those, few do so due to DHT (i.e. they were DHT sensitive in the donor area), but most do so because stem cell exhaustion (due to the original damage during extraction, handling and insertion... a sort of premature aging).
My question is: are these new therapies going to bring some benefit to those follicles, as well?
From what I understand from the theory behind, the answer could be 'yes', but I'm not an expert at all, so I'd like to hear from you.